Loading…

The role of Aβ in Alzheimer’s Disease as an Evolutionary Outcome of Optimized Innate Immune Defense

Alzheimer’s Disease is a progressive manifestation of aging associated with accumulated Amyloid β. It remains frustratingly unclear why this protein accumulates and how it contributes to Alzheimer’s Disease pathology. In one recent hypothesis, Amyloid β is suggested to function as an antimicrobial p...

Full description

Saved in:
Bibliographic Details
Published in:The journal of prevention of Alzheimer's disease 2022-10, Vol.9 (4), p.580-588
Main Author: Tatar, Marc
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 588
container_issue 4
container_start_page 580
container_title The journal of prevention of Alzheimer's disease
container_volume 9
creator Tatar, Marc
description Alzheimer’s Disease is a progressive manifestation of aging associated with accumulated Amyloid β. It remains frustratingly unclear why this protein accumulates and how it contributes to Alzheimer’s Disease pathology. In one recent hypothesis, Amyloid β is suggested to function as an antimicrobial peptide in innate immune defense within the brain, where Amyloid β gains toxicity when it becomes abundant. This essay proposes an evolutionary explanation for why Amyloid β expression is regulated at an optimum based on its function as a defense and how this leads to disease. Among its potential physiological functions, Amyloid β confers benefits to reduce direct pathogen damage while this simultaneously entails cellular cost of defense. Optimal Amyloid β expression occurs when the gain in fitness from an incremental increase is balanced by the marginal cost of this increase. It proposes that natural selection acting upon the young favored systems to maintain Amyloid β at an optimal level through mechanisms that induce the defense and repress its expression. With age, the force of natural selection declines and permits mechanisms of negative feedback repression to degenerate. Consequently, Amyloid β is expressed beyond its optimum. Age also elevates cumulative pathogen exposure, reduces pathogen barriers and reactivates latent pathogens. The net effect is elevated, chronic induction of Amyloid β in the brain. The model recommends attention to innate immune negative regulation in the brain to discover ways to restore these functions toward a youthful state in the elderly.
doi_str_mv 10.14283/jpad.2022.68
format article
fullrecord <record><control><sourceid>pubmedcentral_sprin</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10535726</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_10535726</sourcerecordid><originalsourceid>FETCH-LOGICAL-c360t-b8301b54d28b3fa84f57332fc6e30165e34c69e46b6445792be675cefc302f533</originalsourceid><addsrcrecordid>eNpVkEtOwzAQhi0Eogi6ZO8LpDh-TNwVqkqBSpW6KWvLScetq8Sp4gSJrrgG1-AgHIKTEFo2rGak_6FfHyG3KRulkmtxt9vb9Ygzzkegz8gVlxwSxgHO-59nMlGaZQMyjHHHGEvHKYixviQDAVynAPyKuNUWaVOXSGtHJ1-f1Ac6KQ9b9BU23-8fkT74iDYitZHaQGevddm1vg62eaPLri3q6hhd7ltf-QOu6TwE2yKdV1UXkD6gwxDxhlw4W0Yc_t1r8vI4W02fk8XyaT6dLJJCAGuTXAuW5kquuc6Fs1o6lQnBXQHYC6BQyALGKCEHKVU25jlCpgp0hWDcKSGuyf2pd9_lFa4LDG1jS7NvfNUPNrX15r8S_NZs6leTMiVUxqFvGJ0aYh8KG2zMru6a0I_uPeZI3fxSN7_UDWjxA6qmdro</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The role of Aβ in Alzheimer’s Disease as an Evolutionary Outcome of Optimized Innate Immune Defense</title><source>Springer Nature</source><creator>Tatar, Marc</creator><creatorcontrib>Tatar, Marc</creatorcontrib><description>Alzheimer’s Disease is a progressive manifestation of aging associated with accumulated Amyloid β. It remains frustratingly unclear why this protein accumulates and how it contributes to Alzheimer’s Disease pathology. In one recent hypothesis, Amyloid β is suggested to function as an antimicrobial peptide in innate immune defense within the brain, where Amyloid β gains toxicity when it becomes abundant. This essay proposes an evolutionary explanation for why Amyloid β expression is regulated at an optimum based on its function as a defense and how this leads to disease. Among its potential physiological functions, Amyloid β confers benefits to reduce direct pathogen damage while this simultaneously entails cellular cost of defense. Optimal Amyloid β expression occurs when the gain in fitness from an incremental increase is balanced by the marginal cost of this increase. It proposes that natural selection acting upon the young favored systems to maintain Amyloid β at an optimal level through mechanisms that induce the defense and repress its expression. With age, the force of natural selection declines and permits mechanisms of negative feedback repression to degenerate. Consequently, Amyloid β is expressed beyond its optimum. Age also elevates cumulative pathogen exposure, reduces pathogen barriers and reactivates latent pathogens. The net effect is elevated, chronic induction of Amyloid β in the brain. The model recommends attention to innate immune negative regulation in the brain to discover ways to restore these functions toward a youthful state in the elderly.</description><identifier>ISSN: 2274-5807</identifier><identifier>EISSN: 2426-0266</identifier><identifier>DOI: 10.14283/jpad.2022.68</identifier><identifier>PMID: 36281662</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Geriatrics/Gerontology ; Medicine ; Medicine &amp; Public Health ; Neurology ; Review</subject><ispartof>The journal of prevention of Alzheimer's disease, 2022-10, Vol.9 (4), p.580-588</ispartof><rights>The Author(s) 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids></links><search><creatorcontrib>Tatar, Marc</creatorcontrib><title>The role of Aβ in Alzheimer’s Disease as an Evolutionary Outcome of Optimized Innate Immune Defense</title><title>The journal of prevention of Alzheimer's disease</title><addtitle>J Prev Alzheimers Dis</addtitle><description>Alzheimer’s Disease is a progressive manifestation of aging associated with accumulated Amyloid β. It remains frustratingly unclear why this protein accumulates and how it contributes to Alzheimer’s Disease pathology. In one recent hypothesis, Amyloid β is suggested to function as an antimicrobial peptide in innate immune defense within the brain, where Amyloid β gains toxicity when it becomes abundant. This essay proposes an evolutionary explanation for why Amyloid β expression is regulated at an optimum based on its function as a defense and how this leads to disease. Among its potential physiological functions, Amyloid β confers benefits to reduce direct pathogen damage while this simultaneously entails cellular cost of defense. Optimal Amyloid β expression occurs when the gain in fitness from an incremental increase is balanced by the marginal cost of this increase. It proposes that natural selection acting upon the young favored systems to maintain Amyloid β at an optimal level through mechanisms that induce the defense and repress its expression. With age, the force of natural selection declines and permits mechanisms of negative feedback repression to degenerate. Consequently, Amyloid β is expressed beyond its optimum. Age also elevates cumulative pathogen exposure, reduces pathogen barriers and reactivates latent pathogens. The net effect is elevated, chronic induction of Amyloid β in the brain. The model recommends attention to innate immune negative regulation in the brain to discover ways to restore these functions toward a youthful state in the elderly.</description><subject>Geriatrics/Gerontology</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Neurology</subject><subject>Review</subject><issn>2274-5807</issn><issn>2426-0266</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpVkEtOwzAQhi0Eogi6ZO8LpDh-TNwVqkqBSpW6KWvLScetq8Sp4gSJrrgG1-AgHIKTEFo2rGak_6FfHyG3KRulkmtxt9vb9Ygzzkegz8gVlxwSxgHO-59nMlGaZQMyjHHHGEvHKYixviQDAVynAPyKuNUWaVOXSGtHJ1-f1Ac6KQ9b9BU23-8fkT74iDYitZHaQGevddm1vg62eaPLri3q6hhd7ltf-QOu6TwE2yKdV1UXkD6gwxDxhlw4W0Yc_t1r8vI4W02fk8XyaT6dLJJCAGuTXAuW5kquuc6Fs1o6lQnBXQHYC6BQyALGKCEHKVU25jlCpgp0hWDcKSGuyf2pd9_lFa4LDG1jS7NvfNUPNrX15r8S_NZs6leTMiVUxqFvGJ0aYh8KG2zMru6a0I_uPeZI3fxSN7_UDWjxA6qmdro</recordid><startdate>20221001</startdate><enddate>20221001</enddate><creator>Tatar, Marc</creator><general>Springer International Publishing</general><scope>C6C</scope><scope>5PM</scope></search><sort><creationdate>20221001</creationdate><title>The role of Aβ in Alzheimer’s Disease as an Evolutionary Outcome of Optimized Innate Immune Defense</title><author>Tatar, Marc</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c360t-b8301b54d28b3fa84f57332fc6e30165e34c69e46b6445792be675cefc302f533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Geriatrics/Gerontology</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Neurology</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tatar, Marc</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The journal of prevention of Alzheimer's disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tatar, Marc</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of Aβ in Alzheimer’s Disease as an Evolutionary Outcome of Optimized Innate Immune Defense</atitle><jtitle>The journal of prevention of Alzheimer's disease</jtitle><stitle>J Prev Alzheimers Dis</stitle><date>2022-10-01</date><risdate>2022</risdate><volume>9</volume><issue>4</issue><spage>580</spage><epage>588</epage><pages>580-588</pages><issn>2274-5807</issn><eissn>2426-0266</eissn><abstract>Alzheimer’s Disease is a progressive manifestation of aging associated with accumulated Amyloid β. It remains frustratingly unclear why this protein accumulates and how it contributes to Alzheimer’s Disease pathology. In one recent hypothesis, Amyloid β is suggested to function as an antimicrobial peptide in innate immune defense within the brain, where Amyloid β gains toxicity when it becomes abundant. This essay proposes an evolutionary explanation for why Amyloid β expression is regulated at an optimum based on its function as a defense and how this leads to disease. Among its potential physiological functions, Amyloid β confers benefits to reduce direct pathogen damage while this simultaneously entails cellular cost of defense. Optimal Amyloid β expression occurs when the gain in fitness from an incremental increase is balanced by the marginal cost of this increase. It proposes that natural selection acting upon the young favored systems to maintain Amyloid β at an optimal level through mechanisms that induce the defense and repress its expression. With age, the force of natural selection declines and permits mechanisms of negative feedback repression to degenerate. Consequently, Amyloid β is expressed beyond its optimum. Age also elevates cumulative pathogen exposure, reduces pathogen barriers and reactivates latent pathogens. The net effect is elevated, chronic induction of Amyloid β in the brain. The model recommends attention to innate immune negative regulation in the brain to discover ways to restore these functions toward a youthful state in the elderly.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>36281662</pmid><doi>10.14283/jpad.2022.68</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2274-5807
ispartof The journal of prevention of Alzheimer's disease, 2022-10, Vol.9 (4), p.580-588
issn 2274-5807
2426-0266
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10535726
source Springer Nature
subjects Geriatrics/Gerontology
Medicine
Medicine & Public Health
Neurology
Review
title The role of Aβ in Alzheimer’s Disease as an Evolutionary Outcome of Optimized Innate Immune Defense
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T13%3A16%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_sprin&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20A%CE%B2%20in%20Alzheimer%E2%80%99s%20Disease%20as%20an%20Evolutionary%20Outcome%20of%20Optimized%20Innate%20Immune%20Defense&rft.jtitle=The%20journal%20of%20prevention%20of%20Alzheimer's%20disease&rft.au=Tatar,%20Marc&rft.date=2022-10-01&rft.volume=9&rft.issue=4&rft.spage=580&rft.epage=588&rft.pages=580-588&rft.issn=2274-5807&rft.eissn=2426-0266&rft_id=info:doi/10.14283/jpad.2022.68&rft_dat=%3Cpubmedcentral_sprin%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_10535726%3C/pubmedcentral_sprin%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c360t-b8301b54d28b3fa84f57332fc6e30165e34c69e46b6445792be675cefc302f533%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/36281662&rfr_iscdi=true